Multiple gene expression regulators related to tumor growth

The phrase "multiple gene expression regulators related to tumor growth" refers to a diverse group of molecular entities, including transcription factors (e.g., MYC, CEBPA, GATA family), epigenetic modifiers (e.g., DNA methyltransferases, histone acetylases/deacetylases), and chromatin remodelers (e.g., BRD4, MLL3/MLL4), which modulate gene expression at various genomic loci through mechanisms such as promoter/enhancer binding, chromatin modification, and DNA structure remodeling. Dysregulation of these factors is a hallmark of tumor initiation and progression, impacting processes like proliferation, apoptosis, differentiation, immune evasion, and metastasis[1][3][5][4]. Their collective and individual roles are the subject of intense study for therapeutic targeting and biomarker development in oncology. This entry is too broad and non-specific for direct pharmaceutical targeting, and data should be curated at the level of individual gene regulators or defined molecular complexes for structured use in drug discovery or biomarker annotation.